Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News


EANO 2016

Read Full Story


18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Emory Winship Cancer Institute

The Clinical Neuro-Oncology Program at Emory's Winship Cancer Institute serves as a one stop treatment for patients with brain and spinal cord tumors and functions as a multidisciplinary brain/spinal cord tumor clinic and real time tumor board.

With a team of professionals from the fields of neuropathology, neuroradiology, nuerosurgery, and neuro-oncology and laboratory scientists of the Winship Brain Tumor Program for rapid translational research, and neurosurgery, the Neuro-Oncology team at Winship offers patients faster, more effective treatment.

Directed by Alfredo Voloschin, MD, the Clinical Neuro-Oncology Program holds a weekly Brain Tumor Conference to discuss management of cases from a multidisciplinary team of Neuro-Oncology, Neuro-radiology, Radiation Oncology, Pathology, and Neurosurgery. Jeffrey Olson, MD and Costas Hadjipanayis, MD, PhD are also part of the team.

The Neuro-Oncology Program is a member of the "New Approaches to Brain Tumor Therapy" (NABTT) CNS Consortium. The goal of the program is to improve the therapeutic outcome for adults with primary brain tumors.

This consortium is one of two programs nationwide that is funded by the National Cancer Institute to conduct Phase I and Phase II clinical evaluations of promising new treatment strategies, routes of administrations, and clinical trial design in the treatment of primary malignancies of the central nervous system. The primary goals of the NABTT CNS Consortium are to develop scientific advances and improve clinical outcomes for patients with primary brain tumors.

Winship currently offers treatment trials for newly diagnosed and malignant brain tumors sponsored by NABTT, as well as ones from industrial sources and originated at Emory.


1365-C Clifton Rd. NE
Atlanta GA 30322
(888) 946-7447
(404) 778-1900
(404) 778-5550 fax.